Section Arrow
Quote
QUIT.NASDAQ
- Achieve Life Sciences, Inc.
Quotes are at least 15-min delayed:2026/11/10 17:46 EST
After Hours
Last
 6.29
-0.11 (-1.72%)
Bid
6.29
Ask
6.58
High 6.52 
Low 6.29 
Volume 5.82K 
Regular Hours (Closed)
Last
 6.4
-0.38 (-5.60%)
Day High 
6.78 
Prev. Close
6.78 
1-M High
-- 
Volume 
639.66K 
Bid
6.29
Ask
6.58
Day Low
6.11 
Open
6.64 
1-M Low
-- 
Market Cap 
699.03M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High -- 
52-W Low -- 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.66/-0.66
Enterprise Value
710.22M
Balance Sheet
Book Value Per Share
-0.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
KPTIKaryopharm Therapeutics Inc.0.0174-0.0226-56.50%-- 
After Hours 0.0278 +0.0104 +59.77%
PEPGPepGen4.61+2.22+92.89%-- 
After Hours 5.03 +0.42 +9.11%
ALLOAllogene Therapeutics0.9319-0.1281-12.08%-- 
After Hours 0.94 +0.0081 +0.87%
IBRXImmunityBio6.745-0.365-5.13%-- 
After Hours 6.7312 -0.0138 -0.20%
RXRXRecursion Pharmaceuticals3.55-0.255-6.70%-- 
After Hours 3.57 +0.02 +0.56%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.